Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
Classification of Biomarkers
Examples of Biomarkers
Susceptibility/Risk Biomarkers
Diagnostic Biomarkers
Monitoring Biomarkers
Prognostic Biomarkers
Predictive Biomarkers
Pharmacodynamic (Response) Biomarkers
Safety Biomarkers
Surrogate Biomarkers/Endpoints
Discovery, Verification and Validation
Biomarker Qualification
Applications of Biomarkers
Diagnostics, Therapeutics and Disease Monitoring
Drug Discovery and Development
Clinical Trials

Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Diseases
Advances in Omics and Imaging Technologies
Market Restraints
High Development Costs
Requirement for Skilled Labor
Market Opportunities
Emerging Markets
Personalized Medicine

Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Clinical Trials
Clinical Trial Analysis, by Therapeutic Area
Clinical Trial Analysis, by Study Status
Clinical Trial Analysis, by Study Type
Patent Analysis

Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Biomarkers: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Services
Software
Market Analysis by Technology
Proteomics
Genomics
Imaging
Bioinformatics
Metabolomics
Market Analysis by Therapeutic Area
Cancer
Cardiovascular and Metabolic Diseases
Neurodegenerative Diseases
Infectious Diseases
Autoimmune Diseases
Other Diseases
Market Analysis by End User
Hospitals and Diagnostic Labs
Academic and Research Institutes
Pharmaceutical and Biotech Companies
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence
Ranking of Companies in the Biomarker Industry

Chapter 7 Sustainability in Biomarkers Technologies and Global Markets: An ESG Perspective
Sustainability in the Biomarker Market
ESG Risks and Ratings: Understanding the Data

Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BAYER AG
BD
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
ILLUMINA INC.
JEOL LTD.
KONINKLIJKE PHILIPS N.V.
PROMEGA CORP.
QIAGEN
REVVITY
SHIMADZU CORP.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.



List of Figures

 

Summary Figure A : Global Market for Biomarkers, by Product Type, 2021–2029
Summary Figure B : Global Market for Biomarkers, by Product Type, 2021–2029
Figure 1 : Snapshot of the Market Dynamics of Biomarkers
Figure 2 : Share of Global Market for Biomarkers, by Product Type, 2023
Figure 3 : Share of Global Market for Biomarkers, by Technology, 2023
Figure 4 : Share of Global Market for Biomarkers, by Therapeutic Area, 2023
Figure 5 : Share of Global Market for Biomarkers, by End User, 2023
Figure 6 : Share of Global Market for Biomarkers, by Region, 2023
Figure 7 : Share of North American Market for Biomarkers, by Country, 2023
Figure 8 : Share of European Market for Biomarkers, by Country, 2023
Figure 9 : Share of Asia-Pacific Market for Biomarkers, by Country, 2023
Figure 10 : Share of RoW Market for Biomarkers, by Sub-region, 2023
Figure 11 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 14 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 15 : Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 16 : Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 22 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 28 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 30 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 31 : Illumina: Revenue Share, by Business Unit, FY 2023
Figure 32 : Illumina: Revenue Share, by Country/Region, FY 2023
Figure 33 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 34 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 35 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
Figure 37 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 38 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 39 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 40 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 41 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 42 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
Figure 44 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
Figure 45 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023

List of Tables


Summary Table A : Global Market for Biomarkers, by Product Type, Through 2029
Summary Table B : Global Market for Biomarkers, by Region, Through 2029
Table 1 : Categories of Biomarkers
Table 2 : Examples of Biomarkers
Table 3 : Clinical Trials in Biomarkers, by Therapeutic Area, 2021–2024*
Table 4 : Clinical Trials in Biomarkers, by Study Status, 2021–2024*
Table 5 : Clinical Trials in Biomarkers, by Type of Study, 2021–2024*
Table 6 : Patents Issued for Biomarkers, 2021–2024*
Table 7 : Patents Issued for Biomarkers, by Applicant, 2021–2024*
Table 8 : Global Market for Biomarkers, Through 2029
Table 9 : Global Market for Biomarkers, by Product Type, Through 2029
Table 10 : Global Market for Biomarkers, by Technology, Through 2029
Table 11 : Global Market for Biomarkers, by Therapeutic Area, Through 2029
Table 12 : Global Market for Biomarkers, by End User, Through 2029
Table 13 : Global Market for Biomarkers, by Region, Through 2029
Table 14 : North American Market for Biomarkers, by Country, Through 2029
Table 15 : European Market for Biomarkers, by Country, Through 2029
Table 16 : Asia-Pacific Market for Biomarkers, by Country, Through 2029
Table 17 : RoW Market for Biomarkers, by Sub-region, Through 2029
Table 18 : Market Rankings of Leading Companies in the Biomarker Industry, 2023
Table 19 : ESG Rankings for Major Biomarker Companies, 2024*
Table 20 : Information Sources in This Report
Table 21 : Abbreviations Used in This Report
Table 22 : Abbott: Company Snapshot
Table 23 : Abbott: Financial Performance, FY 2022 and 2023
Table 24 : Abbott: Product Portfolio
Table 25 : Abbott: News/Key Developments, 2023–2024
Table 26 : Agilent Technologies Inc.: Company Snapshot
Table 27 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 28 : Agilent Technologies Inc.: Product Portfolio
Table 29 : Agilent Technologies Inc.: News/Key Developments, 2023–2024
Table 30 : Bayer AG: Company Snapshot
Table 31 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 32 : Bayer AG: Product Portfolio
Table 33 : Bayer AG: News/Key Developments, 2022–2024
Table 34 : BD: Company Snapshot
Table 35 : BD: Financial Performance, FY 2022 and 2023
Table 36 : BD: Product Portfolio
Table 37 : BD: News/Key Developments, 2024
Table 38 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 39 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 41 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 42 : Bruker: Company Snapshot
Table 43 : Bruker: Financial Performance, FY 2022 and 2023
Table 44 : Bruker: Product Portfolio
Table 45 : Bruker: News/Key Developments, 2023
Table 46 : Danaher Corp.: Company Snapshot
Table 47 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 48 : Danaher Corp.: Product Portfolio
Table 49 : Danaher Corp.: News/Key Developments, 2022-2024
Table 50 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 51 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 52 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 53 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023
Table 54 : Fujifilm Holdings Corp.: Company Snapshot
Table 55 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 56 : Fujifilm Holdings Corp.: Product Portfolio
Table 57 : GE Healthcare: Company Snapshot
Table 58 : GE Healthcare: Financial Performance, FY 2022 and 2023
Table 59 : GE Healthcare: Product Portfolio
Table 60 : GE Healthcare: News/Key Developments, 2024
Table 61 : Illumina Inc.: Company Snapshot
Table 62 : Illumina: Financial Performance, FY 2022 and 2023
Table 63 : Illumina: Product Portfolio
Table 64 : Illumina Inc.: News/Key Developments, 2024
Table 65 : JEOL Ltd.: Company Snapshot
Table 66 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 67 : JEOL Ltd.: Product Portfolio
Table 68 : JEOL Ltd.: News/Key Developments, 2023
Table 69 : Koninklijke Philips N.V.: Company Snapshot
Table 70 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 71 : Koninklijke Philips N.V.: Product Portfolio
Table 72 : Koninklijke Philips N.V.: News/Key Developments, 2022 and 2023
Table 73 : Promega Corp.: Company Snapshot
Table 74 : Promega Corp.: Product Portfolio
Table 75 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 76 : Qiagen: Company Snapshot
Table 77 : Qiagen: Financial Performance, FY 2022 and 2023
Table 78 : Qiagen: Product Portfolio
Table 79 : Qiagen: News/Key Developments, 2023
Table 80 : Revvity: Company Snapshot
Table 81 : Revvity: Financial Performance, FY 2022 and 2023
Table 82 : Revvity: Product Portfolio
Table 83 : Revvity: News/Key Developments, 2022 and 2023
Table 84 : Shimadzu Corp.: Company Snapshot
Table 85 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 86 : Shimadzu Corp.: Product Portfolio
Table 87 : Shimadzu Corp.: News/Key Developments, 2023
Table 88 : Siemens Healthineers AG: Company Snapshot
Table 89 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 90 : Siemens Healthineers AG: Product Portfolio
Table 91 : Siemens Healthineers AG: News/Key Developments, 2024
Table 92 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 93 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 94 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 95 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024